Hallmarks of NLRP3 inflammasome activation are observed in organotypic hippocampal slice culture.


Journal

Immunology
ISSN: 1365-2567
Titre abrégé: Immunology
Pays: England
ID NLM: 0374672

Informations de publication

Date de publication:
09 2020
Historique:
received: 20 03 2020
revised: 05 05 2020
accepted: 18 05 2020
pubmed: 24 5 2020
medline: 25 5 2021
entrez: 24 5 2020
Statut: ppublish

Résumé

Microglial inflammation driven by the NACHT, LRR and PYD domain-containing protein 3 (NLRP3) inflammasome contributes to brain disease and is a therapeutic target. Most mechanistic studies on NLRP3 activation use two-dimensional pure microglial cell culture systems. Here we studied the activation of the NLRP3 inflammasome in organotypic hippocampal slices, which allowed us to investigate microglial NLRP3 activation in a three-dimensional, complex tissue architecture. Toll-like receptor 2 and 4 activation primed microglial inflammasome responses in hippocampal slices by increasing NLRP3 and interleukin-1β expression. Nigericin-induced NLRP3 inflammasome activation was dynamically visualized in microglia through ASC speck formation. Downstream caspase-1 activation, gasdermin D cleavage, pyroptotic cell death and interleukin-1β release were also detected, and these findings were consistent when using different NLRP3 stimuli such as ATP and imiquimod. NLRP3 inflammasome pathway inhibitors were effective in organotypic hippocampal slices. Hence, we have highlighted organotypic hippocampal slice culture as a valuable ex vivo tool to allow the future study of NLRP3 inflammasomes in a representative tissue section, aiding the discovery of further mechanistic insights and drug development.

Identifiants

pubmed: 32445196
doi: 10.1111/imm.13221
pmc: PMC7450173
doi:

Substances chimiques

Anti-Bacterial Agents 0
Gsdmd protein, mouse 0
IL1B protein, mouse 0
Interleukin-1beta 0
Intracellular Signaling Peptides and Proteins 0
NLR Family, Pyrin Domain-Containing 3 Protein 0
Nlrp3 protein, mouse 0
Phosphate-Binding Proteins 0
Caspase 1 EC 3.4.22.36
Nigericin RRU6GY95IS

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-52

Subventions

Organisme : Medical Research Council
ID : MR/T016515/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003586/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N013751/1
Pays : United Kingdom

Informations de copyright

© 2020 The Authors. Immunology published by John Wiley & Sons Ltd.

Références

Neuron. 2017 May 17;94(4):759-773.e8
pubmed: 28521131
Mol Cell Neurosci. 2002 Feb;19(2):272-80
pubmed: 11860279
Nature. 2013 Jan 31;493(7434):674-8
pubmed: 23254930
Nat Med. 2015 Mar;21(3):248-55
pubmed: 25686105
Nat Neurosci. 2014 Jan;17(1):131-43
pubmed: 24316888
J Biol Chem. 1994 May 27;269(21):15195-203
pubmed: 8195155
Cell Res. 2015 Dec;25(12):1285-98
pubmed: 26611636
J Biol Chem. 1999 Nov 26;274(48):33835-8
pubmed: 10567338
Nature. 2018 Oct;562(7727):367-372
pubmed: 30283141
Nat Rev Neurosci. 2018 Oct;19(10):610-621
pubmed: 30206330
J Neuroinflammation. 2019 May 18;16(1):106
pubmed: 31103036
Nat Immunol. 2008 Aug;9(8):847-56
pubmed: 18604214
J Neuroinflammation. 2015 Nov 04;12:202
pubmed: 26538404
J Neurosci. 2014 Sep 3;34(36):11929-47
pubmed: 25186741
J Neurochem. 2008 Jul;106(1):271-80
pubmed: 18384650
Nat Neurosci. 2016 Mar;19(3):504-16
pubmed: 26780511
J Cell Sci. 2007 Mar 1;120(Pt 5):772-81
pubmed: 17284521
J Exp Med. 2018 Mar 5;215(3):827-840
pubmed: 29432122
Cell. 2010 Mar 19;140(6):821-32
pubmed: 20303873
Sci Rep. 2018 Apr 4;8(1):5667
pubmed: 29618797
J Neurochem. 2017 Dec;143(5):534-550
pubmed: 28940479
Cell Rep. 2016 Jul 12;16(2):571-582
pubmed: 27346360
Nature. 2019 Nov;575(7784):669-673
pubmed: 31748742
Immunity. 2016 Oct 18;45(4):761-773
pubmed: 27692612
Glia. 2013 May;61(5):813-24
pubmed: 23404620
Annu Rev Physiol. 2017 Feb 10;79:619-643
pubmed: 27959620
J Neuroinflammation. 2018 Jul 11;15(1):203
pubmed: 29996878
Immunity. 2019 Jan 15;50(1):253-271.e6
pubmed: 30471926
Cell Death Differ. 2016 Jul;23(7):1219-31
pubmed: 26868913
Cell Chem Biol. 2017 Nov 16;24(11):1321-1335.e5
pubmed: 28943355
Neuron. 2018 Jan 17;97(2):299-312.e6
pubmed: 29290552
Immunity. 2013 Jun 27;38(6):1142-53
pubmed: 23809161
Glia. 2016 Aug;64(8):1285-97
pubmed: 27145902
Nat Med. 2016 Nov;22(11):1220-1228
pubmed: 27783065
Nat Immunol. 2008 Aug;9(8):857-65
pubmed: 18604209
Nature. 2016 Jul 06;535(7610):153-8
pubmed: 27383986
Nat Rev Immunol. 2019 May;19(5):273-281
pubmed: 30705422
Neuron. 2017 Apr 19;94(2):278-293.e9
pubmed: 28426964
Annu Rev Immunol. 2010;28:321-42
pubmed: 20307211
Nature. 2017 Dec 20;552(7685):355-361
pubmed: 29293211
J Neurosci Methods. 1991 Apr;37(2):173-82
pubmed: 1715499
Eur J Neurosci. 2003 Jul;18(1):85-94
pubmed: 12859340
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7404-7409
pubmed: 29954866
Front Cell Neurosci. 2018 Aug 06;12:242
pubmed: 30127723
J Pharmacol Exp Ther. 2007 May;321(2):509-16
pubmed: 17289835
Nat Immunol. 2014 Aug;15(8):727-37
pubmed: 24952505
ACS Nano. 2018 Dec 26;12(12):11949-11962
pubmed: 30444603
Epilepsia. 2006 Jul;47(7):1160-8
pubmed: 16886979
Neuroscience. 2015 Oct 1;305:86-98
pubmed: 26254240
Nature. 2019 Jun;570(7762):523-527
pubmed: 31168097
Nat Commun. 2018 Aug 1;9(1):3001
pubmed: 30069026
Cell. 2014 Mar 13;156(6):1193-1206
pubmed: 24630722
J Immunol. 2009 Jul 15;183(2):787-91
pubmed: 19570822
Nature. 2015 Oct 29;526(7575):660-5
pubmed: 26375003
Nat Commun. 2018 Oct 9;9(1):4167
pubmed: 30301888
Mol Cell. 2017 Oct 5;68(1):185-197.e6
pubmed: 28943315
Sci Rep. 2016 Jan 18;6:19371
pubmed: 26778406
J Neuroinflammation. 2005 Nov 15;2:25
pubmed: 16285888
Nature. 2019 Feb;566(7744):388-392
pubmed: 30760929
Science. 2008 May 2;320(5876):674-7
pubmed: 18403674
Science. 2005 May 27;308(5726):1314-8
pubmed: 15831717
Nat Neurosci. 2006 Dec;9(12):1512-9
pubmed: 17115040
Cell. 2014 Mar 13;156(6):1207-1222
pubmed: 24630723
J Biol Chem. 2013 Jan 25;288(4):2721-33
pubmed: 23209292
J Neurocytol. 1987 Apr;16(2):249-60
pubmed: 3625239
Cardiovasc Psychiatry Neurol. 2011;2011:646958
pubmed: 21350722

Auteurs

Christopher Hoyle (C)

Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.

Elena Redondo-Castro (E)

Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.

James Cook (J)

Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.

Te-Chen Tzeng (TC)

Immunology and Inflammation, Bristol-Myers Squibb (Celgene Corporation), Cambridge, MA, USA.

Stuart M Allan (SM)

Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.

David Brough (D)

Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.

Eloise Lemarchand (E)

Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH